Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
US economic indicators send mixed signals ahead of market holiday
Post Content Post Views: 107
Earnings call: Duluth Holdings reports Q3 sales decline, eyes growth through new products and strategic investments
Post Content Post Views: 116
US existing home sales slump to more than 13-year low, prices accelerate
Post Content Post Views: 118
Filament Health signs term sheet for a $14.4M convertible note
Post Content Post Views: 132
Hamilton Global Financials ETF declares CAD 0.07 dividend
Post Content Post Views: 112
China’s central bank pledges to support domestic demand
Post Content Post Views: 107